DIMERO D PDF

D-dimer or D dimer is a fibrin degradation product or FDP , a small protein fragment present in the blood after a blood clot is degraded by fibrinolysis. It is so named because it contains two D fragments of the fibrin protein joined by a cross-link. D-dimer concentration may be determined by a blood test to help diagnose thrombosis. Since its introduction in the s, it has become an important test performed in patients with suspected thrombotic disorders. While a negative result practically rules out thrombosis, a positive result can indicate thrombosis but does not rule out other potential causes. Its main use, therefore, is to exclude thromboembolic disease where the probability is low.

Author:Junos Jumi
Country:Singapore
Language:English (Spanish)
Genre:Relationship
Published (Last):12 October 2012
Pages:243
PDF File Size:20.28 Mb
ePub File Size:14.7 Mb
ISBN:311-1-99530-155-6
Downloads:88735
Price:Free* [*Free Regsitration Required]
Uploader:Kajihn



Admission D-dimer can identify low-risk patients with community-acquired pneumonia. Ann Emerg Med ; 53 5 : E Pub Feb 7. Clinical probability and D-dimer testing: how should we use them in clinical practice? Semin Respir Crit Care Med ; 29 1 : The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin.

J Biol Chem ; 8 : Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.

Semin Thromb Hemost ; 27 6 : D-dimer antigen: current concepts and future prospects. Blood ; 13 : Epub Nov Inflammatory and hemostatic biomarkers associated with early recurrent ischemic lesions in acute ischemic stroke. Stroke ; 40 5 : Epub Mar 5. Rosenberg RD. Vascular-bed-specific hemostasis and hypercoagulable states: clinical utility of activation peptide assays in predicting thrombotic events in different clinical populations.

Thromb Haemost ; 86 1 : Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases. J Intern Med ; 3 : Adhesion molecules--Part II: Blood vessels and blood cells. N Engl J Med.

Seminars in medicine of the Beth Israel Hospital, Boston. Platelet-endothelium interactions. Lippincott Williams and Wilkins. Izaguirre AR. Arch Cardiol Mex ; 75 Suppl 3 : S The tissue factor requirement in blood coagulation. J Biol Chem ; 52 : Epub Oct 7. Direct thrombin inhibitors. N Engl J Med ; 10 : Erratum in: N Engl J Med. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med ; 20 : Bauer KA. Selective inhibition of coagulation factors: advances in antithrombotic therapy.

Semin Thromb Hemost ; 28 Suppl 2 : Thrombotic risk factors: basic pathophysiology. Crit Care Med ; 38 2 Suppl : S Vine AK.

Recent advances in haemostasis and thrombosis. Venous thrombosis in the antiphospholipid syndrome. Arterioscler Thromb Vasc Biol ; 29 3 : Thrombophilia, autoimmunity, and perioperative thromboprophylaxis. Cir Cir ; 75 4 : Blood coagulation and the risk of atherothrombosis: a complex relationship.

Thromb J ; 2 1 : The value of family history as a risk indicator for venous thrombosis. Arch Intern Med ; 6 : Venous thrombosis at unusual sites and the role of thrombophilia. Semin Thromb Hemost. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med ; 16 : Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels.

Age Ageing ; 35 1 : Hypercoagulable states: a review. Vasc Endovascular Surg. Voetsch B, Loscalzo J. Genetic determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol ; 24 2 : Bick RL. Cancer-associated thrombosis. The antiphospholipid syndrome. Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol ; 28 3 : The diagnosis and treatment of acute pulmonary embolism.

Dtsch Arztebl Int ; : Epub Aug McRae S. Pulmonary embolism. Aust Fam Physician ; 39 6 : Ho WK. Deep vein thrombosis--risks and diagnosis.

Crit Care Med ; 35 8 : Hypercoagulability markers in patients with peripheral arterial disease: association to ankle-brachial index. Angiology ; 60 5 : Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study. Ann Intern Med ; 2 : Clinical practice.

Acute ischemic stroke. N Engl J Med ; 6 : Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med ; 17 : Guenther G, Arauz A. Neurologia [Epub ahead of print] Spanish.

Do normal D-dimer levels reliably exclude cerebral sinus thrombosis? Stroke ; 35 12 : Epub

CONDIVI VITA DI MICHELANGELO PDF

2018, Número 1

Role of fibrin D-dimer testing in emergency medicine. Emerg Med J. Beck WS. Cambridge Massachusetts: Massachusetts Institute of Technology; Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases. J Intern Med. Adhesion molecules--Part II: Blood vessels and blood cells.

BETTERPHOTO BASICS BY JIM MIOTKE PDF

Prueba de dímero D

Admission D-dimer can identify low-risk patients with community-acquired pneumonia. Ann Emerg Med ; 53 5 : E Pub Feb 7. Clinical probability and D-dimer testing: how should we use them in clinical practice? Semin Respir Crit Care Med ; 29 1 : The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin.

VT6212L PDF

D-Dimer Test

A D-dimer test looks for D-dimer in blood. D-dimer is a protein fragment small piece that's made when a blood clot dissolves in your body. Blood clotting is an important process that prevents you from losing too much blood when you are injured. Normally, your body will dissolve the clot once your injury has healed. With a blood clotting disorder , clots can form when you don't have an obvious injury or don't dissolve when they should. These conditions can be very serious and even life-threatening.

JOTTO DESK FACEPLATES PDF

2011, Número 1

.

Related Articles